1. The Roles of MicroRNA in Lung Cancer
   Kuan-Li Wu et al, 2019, International Journal of Molecular Sciences CrossRef
2. Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies
   Xing Chang et al, 2019, RSC Advances CrossRef
3. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
   Giulia Antoniali et al, 2022, Cellular and Molecular Life Sciences CrossRef
4. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism
   Gui-wei Liu et al, 2018, Human Cell CrossRef
5. miRNA-200c-3p targets talin-1 to regulate integrin-mediated cell adhesion
   Gideon Obeng et al, 2021, Scientific Reports CrossRef
6. ‘Patchiness’ and basic cancer research: unravelling the proteases
   Surinder M Soond et al, 2019, Cell Cycle CrossRef
7. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
   Mateusz Florczuk et al, 2017, Targeted Oncology CrossRef
8. Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
   Jente van Staalduinen et al, 2018, Oncogene CrossRef
9. Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway
   Yanyun Guan et al, 2024, Gene CrossRef
10. MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy
    Milad Ashrafizadeh et al, 2020, Biomolecules CrossRef
11. The Downregulation of miR-200c Promotes Lactate Dehydrogenase A Expression and Non-Small Cell Lung Cancer Progression
    Wei Lei et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
12. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma
    Meiling Yu et al, 2017, Oncology Reports CrossRef
13. Role of Non-Coding RNAs in Lung Cancer
    Maksat Babayev et al, 2022, Recent Advances in Noncoding RNAs CrossRef
14. Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights
    Catherine B. Meador et al, 2020, Pharmacology & Therapeutics CrossRef
15. The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration
    Mehri Ghasabi et al, 2019, Journal of Cellular Physiology CrossRef
16. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review
    Mohammad Saleh Sadeghi et al, 2023, Cancer Cell International CrossRef
17. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance
    Daria Molodtsova et al, 2023, International Journal of Molecular Sciences CrossRef
18. Sulforaphane inhibits human bladder cancer cell invasion by reversing epithelial-to-mesenchymal transition via directly targeting microRNA-200c/ZEB1 axis
    Lei Huang et al, 2018, Journal of Functional Foods CrossRef
19. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231
    Weili Liang et al, 2018, Molecular Medicine Reports CrossRef
20. The Network of Non-coding RNAs in Cancer Drug Resistance
    Fabio Corrà et al, 2018, Frontiers in Oncology CrossRef